ClinicalTrialsFinder

Relapsed/Refractory B- Cell Non-Hodgkin Lymphoma Clinical Trials in Bandar Tun Razak, Kuala Lumpur

1 recruitingBandar Tun Razak, Kuala Lumpur, Malaysia

Showing 1–1 of 1 trials

Recruiting
Phase 2

To Evaluate Safety and Efficacy of Autologous CD19 Chimeric Antigen Receptor (CAR)-T Cells in Relapsed/Refractory B- Non-Hodgkin Lymphoma (B-NHL)

Relapsed/Refractory B- Cell Non-Hodgkin Lymphoma
National University of Malaysia20 enrolled1 locationNCT06698484